Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy

BACKGROUND: Doxorubicin (Dox) is a chemotherapy drug with limited application due to cardiotoxicity that may progress to heart failure. This study aims to evaluate the role of cardiomyocytes derived from mouse embryonic stem cells (CM-mESCs) in the treatment of Dox-induced cardiomyopathy (DIC) in mi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stem Cell Res Ther
Asıl Yazarlar: Silva dos Santos, Danúbia, Brasil, Guilherme Visconde, Ramos, Isalira Peroba Rezende, Mesquita, Fernanda Cristina Paccola, Kasai-Brunswick, Tais Hanae, Christie, Michelle Lopes Araújo, Cahli, Gustavo Monnerat, Barbosa, Raiana Andrade Quintanilha, da Cunha, Sandro Torrentes, Pereira, Jonathas Xavier, Medei, Emiliano, Campos de Carvalho, Antonio Carlos, Carvalho, Adriana Bastos, Goldenberg, Regina Coeli dos Santos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799903/
https://ncbi.nlm.nih.gov/pubmed/29402309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0788-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller